Atrial fibrillation: A major risk factor for cognitive decline

Dawn S. Hui, John E. Morley, Peter C. Mikolajczak, Richard Lee

Research output: Contribution to journalReview article

51 Citations (Scopus)

Abstract

Atrial fibrillation is a common disease of the elderly, conferring considerable morbidity and mortality related to cardiovascular effects and thromboembolic risks. Anticoagulation, antiarrhythmic medications, and rate control are the cornerstone of contemporary management, whereas ablation and evolving surgical techniques continue to play important secondary roles. Growing evidence shows that atrial fibrillation is also a risk factor for significant cognitive decline through a multitude of pathways, further contributing to morbidity and mortality. At the same time, cognitive decline associated with cryptogenic strokes may be the first clue to previously undiagnosed atrial fibrillation. These overlapping associations support the concept of cognitive screening and rhythm monitoring in these populations. New research suggests modulating effects of currently accepted treatments for atrial fibrillation on cognition; however, there remains the need for large multicenter studies to examine the effects of novel oral anticoagulants, rhythm and rate control, and left atrial appendage occlusion on long-term cognitive function.

Original languageEnglish (US)
Pages (from-to)448-456
Number of pages9
JournalAmerican Heart Journal
Volume169
Issue number4
DOIs
StatePublished - Apr 1 2015
Externally publishedYes

Fingerprint

Atrial Fibrillation
Cognition
Morbidity
Atrial Appendage
Mortality
Anticoagulants
Multicenter Studies
Stroke
Cognitive Dysfunction
Research
Population
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Atrial fibrillation : A major risk factor for cognitive decline. / Hui, Dawn S.; Morley, John E.; Mikolajczak, Peter C.; Lee, Richard.

In: American Heart Journal, Vol. 169, No. 4, 01.04.2015, p. 448-456.

Research output: Contribution to journalReview article

Hui, Dawn S. ; Morley, John E. ; Mikolajczak, Peter C. ; Lee, Richard. / Atrial fibrillation : A major risk factor for cognitive decline. In: American Heart Journal. 2015 ; Vol. 169, No. 4. pp. 448-456.
@article{3c7194bf3e4b4d67bb99a5a56e28ab65,
title = "Atrial fibrillation: A major risk factor for cognitive decline",
abstract = "Atrial fibrillation is a common disease of the elderly, conferring considerable morbidity and mortality related to cardiovascular effects and thromboembolic risks. Anticoagulation, antiarrhythmic medications, and rate control are the cornerstone of contemporary management, whereas ablation and evolving surgical techniques continue to play important secondary roles. Growing evidence shows that atrial fibrillation is also a risk factor for significant cognitive decline through a multitude of pathways, further contributing to morbidity and mortality. At the same time, cognitive decline associated with cryptogenic strokes may be the first clue to previously undiagnosed atrial fibrillation. These overlapping associations support the concept of cognitive screening and rhythm monitoring in these populations. New research suggests modulating effects of currently accepted treatments for atrial fibrillation on cognition; however, there remains the need for large multicenter studies to examine the effects of novel oral anticoagulants, rhythm and rate control, and left atrial appendage occlusion on long-term cognitive function.",
author = "Hui, {Dawn S.} and Morley, {John E.} and Mikolajczak, {Peter C.} and Richard Lee",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.ahj.2014.12.015",
language = "English (US)",
volume = "169",
pages = "448--456",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Atrial fibrillation

T2 - A major risk factor for cognitive decline

AU - Hui, Dawn S.

AU - Morley, John E.

AU - Mikolajczak, Peter C.

AU - Lee, Richard

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Atrial fibrillation is a common disease of the elderly, conferring considerable morbidity and mortality related to cardiovascular effects and thromboembolic risks. Anticoagulation, antiarrhythmic medications, and rate control are the cornerstone of contemporary management, whereas ablation and evolving surgical techniques continue to play important secondary roles. Growing evidence shows that atrial fibrillation is also a risk factor for significant cognitive decline through a multitude of pathways, further contributing to morbidity and mortality. At the same time, cognitive decline associated with cryptogenic strokes may be the first clue to previously undiagnosed atrial fibrillation. These overlapping associations support the concept of cognitive screening and rhythm monitoring in these populations. New research suggests modulating effects of currently accepted treatments for atrial fibrillation on cognition; however, there remains the need for large multicenter studies to examine the effects of novel oral anticoagulants, rhythm and rate control, and left atrial appendage occlusion on long-term cognitive function.

AB - Atrial fibrillation is a common disease of the elderly, conferring considerable morbidity and mortality related to cardiovascular effects and thromboembolic risks. Anticoagulation, antiarrhythmic medications, and rate control are the cornerstone of contemporary management, whereas ablation and evolving surgical techniques continue to play important secondary roles. Growing evidence shows that atrial fibrillation is also a risk factor for significant cognitive decline through a multitude of pathways, further contributing to morbidity and mortality. At the same time, cognitive decline associated with cryptogenic strokes may be the first clue to previously undiagnosed atrial fibrillation. These overlapping associations support the concept of cognitive screening and rhythm monitoring in these populations. New research suggests modulating effects of currently accepted treatments for atrial fibrillation on cognition; however, there remains the need for large multicenter studies to examine the effects of novel oral anticoagulants, rhythm and rate control, and left atrial appendage occlusion on long-term cognitive function.

UR - http://www.scopus.com/inward/record.url?scp=84927581555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927581555&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2014.12.015

DO - 10.1016/j.ahj.2014.12.015

M3 - Review article

C2 - 25819850

AN - SCOPUS:84927581555

VL - 169

SP - 448

EP - 456

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4

ER -